KAPA AMEX
Kairos Pharma, Ltd.
1W: -9.3%
1M: -1.3%
3M: -42.6%
YTD: -69.4%
1Y: -80.3%
$1.56
+0.00 (+0.00%)
Weekly Expected Move ±8.7%
$1
$1
$2
$2
$2
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
0
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$4.8M
52W Range1.47-9.59
Volume25,754
Avg Volume265,906
Beta1.48
Dividend—
Analyst Ratings
Company Info
CEOJohn S. Yu
Employees4
SectorHealthcare
IndustryBiotechnology
IPO Date2024-09-16
Websitekairospharma.com
2355 Westwood Blvd.
Los Angeles, CA 90064
US
Los Angeles, CA 90064
US
310-948-2356
About Kairos Pharma, Ltd.
Kairos Pharma, Ltd. operates as a clinical-stage biopharmaceutical company focused on developing innovative treatments for individuals battling cancer. Its therapeutic portfolio includes a range of antibodies and small molecules engineered to combat various malignancies, such as prostate, lung, and breast cancer, as well as glioblastoma. Initially incorporated in 2013 under the name NanoGB13, Inc., the enterprise officially adopted its current identity as Kairos Pharma, Ltd. in July 2016. The company's operations are headquartered in Los Angeles, California.
Latest News
All You Need to Know About Kairos Pharma, Ltd. (KAPA) Rating Upgrade to Buy
12 Health Care Stocks Moving In Friday's After-Market Session
KAPA Investors Have Opportunity to Join Kairos Pharma, Ltd. Fraud Investigation with the Schall Law Firm
HC Wainwright Weighs in on Kairos Pharma FY2026 Earnings
HC Wainwright Forecasts Kairos Pharma Q1 Earnings
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Bhowmick Neil | A-Award | 171,756 | — | 2025-10-08 |
| Bae Hyun W. | A-Award | 19,084 | — | 2025-10-08 |
| Murali Ramachandran | A-Award | 152,672 | — | 2025-10-08 |
| Keyoung Hansoo Micha | A-Award | 19,084 | — | 2025-10-08 |
| Singhvi Rahul | A-Award | 19,084 | — | 2025-10-08 |